Vancouver, British Columbia – TheNewswire - February 24, 2023 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) provides an update on the Dory Property Option Agreement dated January 18, 2023 and the change of business announced by the Company’s news release dated January 18, 2023.

The Company is in the process of completing National Instrument 43-101 Technical Report on the Dory Property located in British Columbia.  The Company expects to have the completed technical report within approximately four to eight weeks.

Trading of the Company’s common shares on the Canadian Securities Exchange (the “CSE”) will be halted and will remain halted until the documentation required by the Exchange, including the technical report, are filed and accepted.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer

Telephone: (604) 928-8913

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.